Merck KGaA Reports Q1 2025 Financials with 2.5% Organic Sales Growth
Merck KGaA (ETR: MRK) released its Q1 2025 financial results, reporting a 2.5% year-on-year (YOY)...
Company
CanSino Biologics Gets Indonesian Approval for Phase I Trial of Inhalable Tuberculosis Vaccine
China-based CanSino Biologics Inc. (HKG: 6185), a specialist in vaccine development, has announced that it...
Haisco Pharma’s HSK21542 Approved by NMPA for Post-Abdominal Surgery Pain
Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced that it has received marketing approval...
Lifetech Scientific’s Aortic Arch Stent System Approved by China’s NMPA
China-based Lifetech Scientific Corporation (HKG: 1302) has announced that it has received marketing approval from...
Sihuan Pharmaceutical’s Bireociclib Approved by NMPA for Advanced Breast Cancer
China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) announced that the National Medical Products Administration...
CANbridge’s Velaglucerase β Approved by NMPA for Gaucher’s Disease Long-Term Therapy
China-based CANbridge Pharmaceuticals Inc. (HKG: 1228) announced that the National Medical Products Administration (NMPA) has...
Merck KGaA and JD Health Launch Online Thyroid Care Center in China
The Thyroid Care Center on the JD Health platform, a joint initiative between German pharmaceutical...
Novartis’ Scemblix Approved by NMPA for Newly Diagnosed Ph+ CML-CP Patients
Swiss pharmaceutical company Novartis (NYSE: NVS) announced that it has received marketing approval from China’s...
AbbVie’s Emrelis Granted FDA Accelerated Approval for NSCLC with High c-MET Overexpression
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to AbbVie’s (NYSE: ABBV)...
BeiGene Announces Plans to Relocate Headquarters to Switzerland from Cayman Islands
BeiGene, Ltd. (NASDAQ: ONC, HKG: 6160, SHA: 688235), the China-based oncology company that has proposed...
Chengdu Kanghong’s KH607 Approved for Clinical Trials in Postpartum Depression
China-based Chengdu Kanghong Pharmaceutical Group Co., Ltd. (SHE: 002773) has announced that it has received...
Boehringer Ingelheim’s Nerandomilast Filing Accepted for Review in Progressive Pulmonary Fibrosis
Boehringer Ingelheim announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products...
Novartis’ Kisqali Receives NMPA Approval for High-Risk Early Breast Cancer
Switzerland-based Novartis (NYSE: NVS) announced this week that it has received another indication approval from...
MGI Tech Partners with Genoks to Enhance Clinical Testing Services in Türkiye
China-based gene sequencing specialist MGI Tech Co., Ltd. (SHA: 688114) has entered into a strategic...
Jiangsu Hengrui Pharmaceuticals Launches Hong Kong IPO of H-Shares
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has officially launched an initial public offering...
CSPC Pharma Licenses Irinotecan Liposome Injection to Cipla for US Market
China-based CSPC Pharmaceutical Group Ltd. (HKG: 1093) has entered into a licensing agreement with India-headquartered...
WuHan Hamilton Biotech’s HUC-MSCs Product Approved for Clinical Trials in Premature Ovarian Failure
China-based WuHan Hamilton Biotechnology Co., Ltd. has announced receiving clinical trial approval from the National...
Roche’s VENTANA MET (SP44) RxDx Assay Gains FDA Approval for NSQ-NSCLC Patients
Swiss giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced that the FDA has approved the VENTANA®...
Novo Nordisk and Septerna Ink $2.2 Billion Deal for GPCR Drug Discovery
Denmark-based Novo Nordisk (NYSE: NVO, CPH: NOVO-B) and Septerna, Inc. (NASDAQ: SEPN) announced an exclusive...
Sanofi Announces $20 Billion Investment in US R&D and Manufacturing by 2030
French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced its intention to invest at least $20...